Ten challenging questions about SARS-CoV-2 and COVID-19.
COVID-19
SARS-CoV-2
challenging questions
infectious disease
Journal
Expert review of respiratory medicine
ISSN: 1747-6356
Titre abrégé: Expert Rev Respir Med
Pays: England
ID NLM: 101278196
Informations de publication
Date de publication:
09 2020
09 2020
Historique:
pubmed:
17
6
2020
medline:
6
10
2020
entrez:
16
6
2020
Statut:
ppublish
Résumé
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) recently introduced as a global public health problem by the World Health Organization (WHO). The virus outbreak has been documented around the world. Updating data in different aspects of the virus could force us to revise our idea about the main questions concerning coronavirus disease-19 (COVID-19). Although our knowledge about the SARS-CoV-2 and COVID-19 is largely based on the very limited data, the information is growing rapidly. The renewed answers to the specific research questions concerning updating data not only reveal gaps for future research but also re-categorized our information. Here, we attempt to briefly discuss 10 important questions about SARS-CoV-2 and COVID-19. Since our knowledge about different aspects of SARS-CoV-2 appears to be in its infancy and is rapidly changing, the provision of the right data is more difficult in this regard. However, we try to rely on results from more extensive research to answer the main questions about this new virus. Therefore, further studies, particularly in the context of the virus pathogenesis, diagnosis, treatment, and vaccine development, are warranted.
Identifiants
pubmed: 32536226
doi: 10.1080/17476348.2020.1782197
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM